The US House of Representatives has passed a bill that would allow terminally ill patients access to experimental drugs, NPR reports. It adds that the "right-to-try" bill was already passed by the Senate and now is heading to President Donald Trump, who is expected to sign it into law.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.